Hospira Buprenorphine Hydrochloride Injection and Labetalol Hydrochloride Injection - recalled due to Packaging Defect, USA
3 weeks ago •source fda.gov • details
Recall notice
2 years ago • business
Regulatory Report
385 Hillside Avenue, Hillside, 07205 New Jersey, United States
1) The company does not have a COVID-19 infection control plan in place. Health screening with temperature checks are not performed for employees entering facility, and some staff walk through the factory without wearing a mask. Employees who had to self-quarantine due to contacts with positive/suspected individuals were fired. 2) Walking aisles are cluttered with excessive materials storage, posing trip hazard.3 weeks ago •source fda.gov • details
Recall notice
2 weeks ago •reported by user-thbhr618 • details
4 weeks ago •reported by user-tgcg2937 • details
3 weeks ago •source cdc.gov • details
Outbreak
2 weeks ago •reported by user-hctnw151 • details
2 weeks ago •reported by user-hrdb8654 • details
3 weeks ago •reported by user-jwjzz494 • details
1 week ago •reported by user-dnzyw642 • details
2 weeks ago •reported by user-xnxw1233 • details
4 weeks ago •reported by user-cwnw7178 • details
Search